Abbott Labs reports 3.2 percent rise in sales

[July 20, 2016]  (Reuters) - Abbott Laboratories reported a 3.2 percent rise in quarterly sales, helped by strength in its branded generics and medical device businesses.

Net earnings from continuing operations were $812 million, or 40 cents per share, in the second quarter ended June 30, compared with $786 million, or 52 cents per share, a year earlier. (http://prn.to/2atEUVO)

The company's net sales rose to $5.33 billion from $5.17 billion.

(Reporting by Amrutha Penumudi in Bengaluru; Editing by Maju Samuel)

[© 2016 Thomson Reuters. All rights reserved.]

Copyright 2016 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.